Our partner is focused on developing vaccines for infectious diseases, with an emphasis on tackling global health challenges. Their innovative approach aims to provide effective prevention solutions, addressing unmet medical needs and improving public health outcomes.

This critical hire built the team and led efforts to develop an autologous human TCR-engineered T-cell product manufacturing process. They played an integral part of our partner's Technology Development and Manufacturing team, which was preparing for the clinical development of new T-cell therapy targets discovered using proprietary platform technologies.